Dec 15,2016

One Drop Announces Partnership with the National Health Insurance Company - Daman, The UAE’s Leading Specialized Health Insurer, and Implementation of the One Drop

One Drop today announced that The National Health Insurance Company – Daman (“Daman”), the UAE's largest and most innovative health insurer, has chosen One Drop to lead its digital and mobile health innovation efforts in diabetes. One Drop's enterprise solution, One Drop | Professional, has been implemented by Daman to empower its members living with diabetes to monitor and take charge of their health through easy-to-use, accessible technology.

COLLABORATION PARTNERSHIP

#insurance

#coaching

View Analyst & Ambassador Comments
Go to original news
Dec 19,2016

POCTech achieved the first CE certificate of CGMS

Continuous Glucose Monitoring system of POCTech Corporation received first CE certificate, it is a key point for this product to get into European medical market.

REGULATORY CE MARK

#cgm

View Analyst & Ambassador Comments
Go to original news
Dec 20,2016

Insulet Corporation to Present at Upcoming Investor Conference

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced that management will present at the 35th Annual J.P. Morgan Healthcare Conference in San Francisco, California on Monday, January 9th, 2017 at 3:30 p.m. Pacific Time.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Jan 05,2015

Kevin Sayer Assumes Role of President and Chief Executive Officer; Terry Gregg Transitions to Role of Executive Chairman

Dexcom announced that Kevin Sayer, currently the Company's President and Chief Operating Officer, has assumed the role of President and Chief Executive Officer to succeed Terry Gregg, who is transitioning to the role of Executive Chairman after more than seven years of service as DexCom’s President and Chief Executive Officer.

View Analyst & Ambassador Comments
Go to original news
Jan 05,2015

Insulet Corporation to Present at the 33rd Annual J.P. Morgan Healthcare Conference

Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, plans to participate in the 33rd Annual J.P. Morgan Healthcare Conference taking place in San Francisco. Management is scheduled to present an overview of the Company on Wednesday, January 14, 2015 at 1:30 p.m. Pacific Time.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Jan 07,2015

BD to Present at the 33rd Annual J. P. Morgan Healthcare Conference

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the 33(rd) Annual J. P. Morgan Healthcare Conference on Wednesday, January 14, 2015, at 12:30 p.m. (EST).

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Jan 07,2015

Insulet Updates Fourth Quarter Financial Guidance

Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today updated fourth quarter 2014 guidance to reflect a delay in shipments of its non-insulin drug delivery products from the fourth quarter of 2014 to the first quarter of 2015. As a result of this delay, for the fourth quarter of 2014, the Company expects that revenue will be in the range of $71 to $73 million, versus prior estimates of $76 to $81 million.

View Analyst & Ambassador Comments
Go to original news
Jan 07,2015

Insulet Strengthens Management Team to Drive Sustained Growth

Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced a number of management team changes, including the appointment of six distinguished executives to commercial and corporate positions.

View Analyst & Ambassador Comments
Go to original news
Jan 08,2015

BD Announces Live Webcast Of First Fiscal Quarter Earnings Conference Call

BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it will conduct a live webcast of its first fiscal quarter 2015 earnings conference call on Thursday, February 5, 2015, at 8:00 a.m. (ET). BD will issue a press release detailing the quarter's earnings earlier that morning.

View Analyst & Ambassador Comments
Go to original news
Jan 12,2015

Tandem Diabetes Care Announces FDA Clearance of the t:flex™ Insulin Pump

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® Insulin Pump, today announced that the U.S. Food and Drug Administration (FDA) has granted the Company clearance to market the t:flex™ Insulin Pump. At 480 units, the insulin reservoir of the t:flex Pump has the largest capacity currently available in the United States.

REGULATORY FDA

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES